disaster because of fears for contamination, the Japanese people refused to buy food produced in the region, anyway. Experiments would be done to find out whether camelina was capable of extracting radioactive caesium from the soil. An experiment with sunflowers had no success. Animal feed Camelina has been approved as a cattle feed supplement in the US, as well as an ingredient (up to 10% of the ration) in broiler chicken feed and laying hen feed. Camelina meal, the byproduct of camelina when the oil has been extracted, has a significant crude protein content. "Feeding camelina meal significantly increased (p < 0.01) omega-3 [fatty acid] concentration in both breast and thigh meat [of turkeys] compared to control group." Medical research indicates a diet abundant in omega-3 fatty acids is beneficial to human health. Camelina oil has also been investigated as a sustainable lipid source to fully replace fish oil in diets for farmed Atlantic salmon, rainbow trout, and Atlantic cod. However, various antinutritional factors are present in camelina oil meal and can affect its use as livestock feed. The use of camelina meal for animal feed is only limited by the presence of glucosinolates. The Canadian Food Inspection Agency has approved feeding cold-pressed non-solvent extracted Camelina meal to broiler chickens at up to 12% inclusion. Use in Canada Approximately 50,000 acres are currently cultivated in Canada. The Camelina Association of Canada projects Canada estimates that 1 to 3 million acres could be planted in the future. Several factors challenge the spread of camelina cultivation in Canada: it does not have government crop classification, and camelina meal is not approved as livestock feed. In early 2010, Health Canada approved camelina oil as a food in Canada. In 2014, camelina was included for the first time in Canada's Advance Payments Program (APP), commonly known as the cash advance program. Genetics The first full genome sequence for Camelina was released on 1 August 2013, by a Canadian research team. The genome sequence and its annotation are available in a genome viewer format and enabled for sequence searching and alignment. Technical details of Camelina's genome sequence were published on 23 April 2014 in the academic journal Nature Communications. In 2013 Rothamsted Research in the UK reported they had developed a genetically modified form of Camelina sativa that produced Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA). EPA and DHA are omega-3 fatty acids which are